John F Burd,
Burd was the the Founder & CEO of DexCom, Inc., now the leader in continuous glucose monitoring. In 2017 he founded Lysulin, Inc, in order to launch a natural, scientifically proven nutraceutical product proven to improve the health of people with diabetes. The product, Lysulin was launched in January of 2018 and has been proven to work in double-blind placebo-controlled studies. He is also the founder and CEO of Wonder Spray, llc., a product to treat wound healing and other ailments. Dr Burd has authored over 40 publications and hold 35 issued patents. In 2010 he was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.